跳至主要内容

MedPath Trial Home

机构资讯 AI 研究

数据来源：ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

搜索试验。追踪管线。洞察审批。由 AI 驱动的临床研究情报平台。

产品

临床试验
药物情报
全球审批
深度研究
价格方案

资源

常见问题
搜索

公司

资讯
关于我们
联系我们

法律

隐私政策
服务条款

免责声明： 本网站提供信息检索和数据分析服务。内容不构成医疗建议。适应性评估仅供参考，不能替代合格医疗专业人员的咨询。数据来源于公共注册库和监管机构；MedPath 不保证数据的完整性或准确性。请以原始资料为准。

© 2026 MedPath Trial 版权所有

服务条款隐私政策

我们重视您的隐私

我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。

Tokai University School of Medicine

首页临床试验发起方与机构Tokai University School of Medicine

Tokai University School of Medicine

ACTIVE

神奈川县, 日本www.med.u-tokai.ac.jpPrivate

别名:

school of medicine, tokai university

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

相关临床试验

57

6 进行中

药物批准

0

批准总数

监管机构

0

监管机构数

成立时间

N/A

概览

试验阶段分布

阶段

试验数

占比

不适用

42

73.7%

1 期

6

10.5%

2 期

4

7.0%

Unknown

3

5.3%

3 期

1

1.8%

4 期

1

1.8%

试验状态分布

已完成

39

68.4%

尚未招募

6

10.5%

招募中

12

21.1%

相关临床试验

该机构主办的试验（57）

Analysis of the association between LOX-index and arteriosclerosis detailed examination in recipients of general check-up

Jan 2024300 名受试者

Elucidation of the role of Receptor activator of nuclear factor kappa-B (RANK)/RANK ligand (RANKL) signals in the onset and progression of primary biliary cholangitis

Dec 202340 名受试者

Feasibility Study of Cognitive-Behavioral Therapy for Lifestyle Change in Patients with Non-Alcoholic Fatty Liver Disease (FIT study)

May 202330 名受试者

Clinicopathological significance of Alpha-2-glycoprotein 1 expression in triple-negative breast cancer

Dec 202160 名受试者

Evaluation of the affect in the detection of significant prostate cancer by the characteristics of the biopsy needle

Oct 202090 名受试者

Elucidation of tumor immuno-regulatory mechanism via androgen receptor signal in breast cancer

Aug 202045 名受试者

FOLLOW-UP Trauma: Functional Outcomes, quality of Life, and Long-term patient OWn histories after Trauma survival

Aug 20201000 名受试者

Prospective randomized study of the evaluation of the efficacy and the invasiveness in the treatment of benign prostatic hyperplasia with transurethral thulium laser surgery and transurethral resection of the prostate

Mar 2020140 名受试者

药物批准

暂无批准数据

资讯

Japan's Non-Partisan Diet Members Briefed on Hearing Loss Policy Challenges and Regional Cancer Care Disparities

- Health and Global Policy Institute (HGPI) hosted two non-partisan Diet member briefings addressing hearing loss policy challenges and regional cancer care equalization in Japan. - Professor Koichiro Wasano of Tokai University presented the current status and policy challenges of addressing hearing loss in Japan to legislators. - Professors Kazuhiro Tateda and Masaki Tanabe discussed the tension between equalization and centralization in regional cancer care delivery. - The briefings aimed to deepen legislative understanding using concrete data on high public-interest themes including cancer, preventive medicine, and pediatrics.

本页目录

概览
相关临床试验57
药物批准
资讯1

返回机构列表